Bank of New York Mellon Corp - ENDOCYTE INC ownership

ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 92 filers reported holding ENDOCYTE INC in Q4 2013. The put-call ratio across all filers is 0.93 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of ENDOCYTE INC
ValueSharesWeighting
Q3 2018$4,910,000
+46.4%
276,411
+13.7%
0.00%0.0%
Q2 2018$3,354,000
+601.7%
243,049
+362.8%
0.00%
Q1 2018$478,000
+118.3%
52,512
+2.3%
0.00%
Q4 2017$219,000
+346.9%
51,313
+46.5%
0.00%
Q3 2017$49,000
-7.5%
35,0300.0%0.00%
Q2 2017$53,000
-85.6%
35,030
-75.6%
0.00%
Q1 2017$369,000
+5.4%
143,552
+4.7%
0.00%
Q4 2016$350,000
-13.8%
137,083
+4.2%
0.00%
Q3 2016$406,000
-16.8%
131,546
-13.5%
0.00%
Q2 2016$488,000
+6.1%
152,012
+2.4%
0.00%
Q1 2016$460,000
-18.1%
148,451
+6.0%
0.00%
Q4 2015$562,000
-41.8%
140,072
-33.5%
0.00%
Q3 2015$965,000
-28.4%
210,758
-18.8%
0.00%
Q2 2015$1,348,000
-8.2%
259,695
+10.7%
0.00%
Q1 2015$1,469,000
+7.7%
234,646
+8.1%
0.00%
Q4 2014$1,364,000
-1.9%
217,009
-5.2%
0.00%
Q3 2014$1,391,000
-46.0%
228,880
-41.4%
0.00%
Q2 2014$2,576,000
-38.5%
390,700
+122.0%
0.00%
-100.0%
Q1 2014$4,189,000
+134.2%
175,979
+5.0%
0.00%
Q4 2013$1,789,000
-58.4%
167,523
-48.1%
0.00%
-100.0%
Q3 2013$4,302,000
+117.1%
322,842
+113.9%
0.00%0.0%
Q2 2013$1,982,000150,9490.00%
Other shareholders
ENDOCYTE INC shareholders Q4 2013
NameSharesValueWeighting ↓
VHCP Management II, LLC 4,211,302$74,793,00019.97%
VHCP Management III, LLC 600,000$10,656,0008.05%
RA Capital Management 6,196,143$110,043,0005.88%
GREAT POINT PARTNERS LLC 1,606,100$28,524,0004.44%
Avoro Capital Advisors LLC 5,301,718$94,159,0004.32%
Ghost Tree Capital, LLC 1,100,000$19,536,0004.15%
Crosspoint Capital Strategies, LLC 104,573$1,857,0003.04%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,514,084$62,410,0002.24%
NEXTHERA CAPITAL LP 654,532$11,624,0002.23%
EMORY UNIVERSITY 148,628$2,640,0001.73%
View complete list of ENDOCYTE INC shareholders